So pleased to see that EMvision are blinded to the trial findings until completion and that the trial is being independently managed as per:
" The Pivotal (Validation) Trial will have an independent Trial Steering Committee (TSC) and Data Safety Monitoring Board (DSMB), who will meet periodically to ensure the study progresses effectively and safely, as is best practice"
This is smart as it totally removes any potential perception in the market that the trial outcomes have been doctored or misrepresented in some way.
Also smart to be undertaking the parallel 'algorithm innovation' study. By the end of the 2 trials they should have done enough algo tweaking to make this tech a clear market leader.
EMV Price at posting:
$1.98 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)